[Therapeutic use and adverse events of incretin-related drugs].
Nihon Rinsho · 2012
Last updated 2026-05-28| Journal | Nihon Rinsho, 2012 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash, Heart Failure |
Full record and abstract on PubMed 22768601 ↗